培养的大鼠三叉神经节细胞钙激活钾通道的氧化性调节

目的：研究氧化还原药物对三叉神经节细胞离子通道的调节作用。方法：采用全细胞膜片钳电生理方法,记录氧化还原药物对三叉神经节细胞大电导钙激活钾通道（BKca）的影响。结果：蛋氨酸特异性氧化剂chloramine-T（Ch—T）1mmol／L可轻微增加通道电流幅值,但该作用不能被半胱氨酸还原剂1,4-dithio-DL-threitol（DTT）所逆转。相反,半胱氨酸特异性氧化剂5,5’-dithio-bis（2-nitribenzoic acid）（DTNB）500μmol／L降低BKCa的电流幅值,此作用可被DTT 2mmol／L所逆转。结论：ROS通过氧化调节BKCa通道而参与三叉神经节细胞的功能调节,BKCa通道在氧化应激相关性生理、病理状态下起重要的调节作用。     

膜脂物理属性及化学成分对BKCa钾离子通道的调节作用

大电导钙激活电压门控型钾离子通道(BKCa通道)广泛分布于各种组织中,主要由胞内钙离子浓度增加和细胞膜去极化而激活.此外多种膜脂,如脂肪酸、胆固醇、鞘糖脂等可修饰该通道的功能.该通道参与细胞内信号转导、细胞的兴奋及代谢调节等多种生理过程,其功能异常牵涉到特发性癫痫、高血压等疾病的发生.因而对BKCa通道功能的调节作用的研究具有重要的生理学及病理学意义.文章将主要介绍膜脂对BKCa通道功能的调节作用.     

血管平滑肌细胞中大电导钙激活钾通道的调节作用

大电导钙激活钾通道(BKCa)广泛分布于血管平滑肌细胞(VSMCs).由通道组成亚基α和调节亚基β构成.BKCa在细胞膜电位以及血管张力方面有重要的调节作用,并且与高血压等心血管类疾病的发生也有密切的关系.本文就BKCa通道的分子结构、生理功能及其与心血管疾病的关系研究进展作一综述.     

BKCa增龄变化及其与血压的相关性

目的：探讨大电导钙激活钾通道（BKCa,MaxiK）增龄变化及其与血压水平的关系。方法：选取雄性9、15、21、27、33周龄自发高血压大鼠（SHR）及对照组正常血压大鼠（WKY）,每周龄两类大鼠各4只;测定各周龄SHR和WKY的腹主动脉血压;分离肠系膜小动脉及其血管平滑肌细胞;利用膜片钳全细胞模式记录肠系膜小动脉VSMCs钾电流、用四乙胺（TEA）阻断BKCa后的电流、膜电容,以计算BKCa电流值、BKCa电流密度;探讨BKCa电流密度增龄变化与血压的关系。结果：SHR肠系膜小动脉血管平滑肌细胞（VSMCs）BKCa电流密度随增龄降低,而WKY随增龄的变化无统计学意义（P〉0．05）;SHR肠系膜小动脉VSMCs BKCa电流密度与腹主动脉MABP高度相关（r=-0．7174）,而WKY肠系膜小动脉VSMCs BKCa电流密度与腹主动脉MABP低度相关（r=-0．4832）。结论：BKCa电流和电流密度随增龄衰减,血压水平是衰减程度的重要反应;BKCa电流密度与血压水平高度相关。     

大黄素增加BK_(Ca)通道β_1亚基表达介导自发性高血压大鼠脑基底动脉舒张

本文旨在研究大黄素干预后自发性高血压大鼠(spontaneously hypertensive rat,SHR)脑基底动脉平滑肌细胞BKCa通道电生理特性和表达的变化。在使用大黄素干预处理前后,用尾动脉测压仪观察血压变化,用全细胞膜片钳记录技术观察SHR脑基底动脉平滑肌细胞BKCa通道电流的变化,用免疫组织化学染色和Western Blot观察平滑肌细胞BKCa通道表达变化。结果显示,大黄素干预后,SHR血压由(223±16)mmHg显著降低至(127±12)mmHg(P0.01),与Wistar大鼠相比没有统计学差异。大黄素显著增加SHR平滑肌细胞外向电流(P0.05),该增强作用可被BKCa通道特异性阻断剂IbTX所阻断。大黄素干预后SHR基底动脉平滑肌BKCa通道β1亚基表达明显上调(P0.01)。以上结果提示,大黄素可能通过增加BKCa通道β1亚基表达,增强BKCa通道介导的外向电流,从而发挥舒张SHR脑基底动脉的作用。     

常氧和急性低氧下大鼠传导性肺动脉平滑肌细胞的电生理特性

本文旨在研究大鼠传导性肺动脉平滑肌细胞（pulmonary artery smooth muscle cells,PASMCs）的电生理特征及对急性低氧的反应。用酶解法急性分离出1-2级分支的PASMCs,通过全细胞膜片钳方法研究常氧及急性低氧状况下细胞钾电流的差异,并在常氧下先后使用iBTX和4-AP阻断大电导钙激活钾离子（large conductance Ca-activated K^＋,BKCa）通道及延迟整流性钾离子（delayed rectifier K^＋,KDR）通道后,观察细胞钾电流特征。根据细胞的大小、形态及电生理特征可将PASMCs分为Ⅰ、Ⅱ、Ⅲ类。iBTX对Ⅰ类细胞几乎无作用,而4-AP几乎完全阻断它的钾电流;Ⅱ类细胞的钾电流在加入iBTX后大部分被抑制,其余的对4．AP敏感;Ⅲ类细胞的钾电流对iBTX及4-AP均敏感。急性低氧对三类细胞的钾电流均有不同程度的抑制,并使Ⅰ类细胞的膜电位显著升高,而Ⅱ、Ⅲ类细胞膜电位升高的程度不如Ⅰ类显著。结果表明,传导性肺动脉有3种形态及电生理特性不同的PASMCs,在急性低氧时其钾电流不同程度地受到抑制,同时静息膜电位也有不同程度去极化,这些可能参与急性低氧时传导性肺动脉舒缩反应的调节。KDR及BKCa通道在3种细胞中的比例不同可能是急性低氧对3种PASMCs影响不同的离子基础。     

模拟失重增强大鼠脑动脉血管平滑肌细胞大电导钙激活钾通道功能

本工作旨在探讨短期模拟失重大鼠脑动脉血管平滑肌细胞（vascular smooth muscle cells,VSMCs）大电导钙激活钾通道（large conductance calcium-activated potassium channels,BKCa channels）功能的改变。以尾部悬吊大鼠模型模拟失重对脑血管的影响。应用激光扫描共聚焦显微镜测定VSMCs胞内游离钙浓度（[Ca^2＋]i）;采用细胞贴附模式,记录BKCa通道的单通道活动。结果表明,模拟失重1周后,大鼠脑动脉VSMCs的[Ca^2＋]i比对照组显著升高（P〈0．05）：BKCa通道的开放概率（Po）与平均开放时间（To）显著增加（P〈0．05）,而单通道电导与平均关闭时间（Tc）则无显著变化。总之,1周模拟失重可引起脑动脉VSMCs的BKCa通道功能显著增强,且与细胞[Ca^2＋]i的升高同步出现。结果提示,脑动脉VSMCs的离子通道机制可能参与介导模拟失重引起的脑血管适应性变化。     

香烟提取物活化大鼠支气管平滑肌细胞蛋白激酶C亚型及下调钾通道BK_(Ca)、Kv1.5表达(英文)

大电导的钙活化钾通道（large—conductance calcium—activated potassium channel,BKCa）和电压依赖性钾通道Kv1．5在气道高反应性的发生机制中具有重要作用。已知吸烟可致气道高反应,但钾通道的变化在其发病中的作用尚需进一步阐明。本文旨在研究香烟提取物（cigarette smoke extract,CSE）对培养的大鼠支气管平滑肌细胞（bronchial smooth muscle cells,BSMCs）钾通道BKCa和Kv1．5表达的直接作用,以及蛋白激酶C（protein kinaseC,PKC）在其中的作用。实验采用原代培养大鼠BSMCs,用5％CSE刺激,免疫印迹检测PKC亚型的表达和转位,半定量RT—PCR、免疫印迹实验检测BKCa和Kv1．5的mRNA和蛋白表达,然后用PKC抑制剂BIM和G6e6983与CSE共作用,检测其对BKCa和Kv1．5的mRNA和蛋白表达的影响。结果显示,5％CSE使PKCε、η、θ发生明显的膜转位,并使BKCa。和Kv1．5的蛋白和mRNA表达明显降低;选择性PKC抑制剂BIM或G6e6983与CSE共同作用,均可使BKCa和Kv1．5的蛋白和mRNA表达部分恢复。上述结果提示,CSE可引起BSMCs的BKCa和Kv1．5表达下调,PKCε、η、θ参与其信号转导。     

大电导钙激活钾通道对大鼠骨髓间充质干细胞增殖的影响

为了观察开放和拮抗大电导钙激活钾通道（bigconductanceCa2＋-activated砧channel．BKca）对大鼠骨髓间充质干细胞（bonemarrowmesenchymalstemcells,BMSCs）增殖的影响并探讨其机制,该研究分离培养了大鼠BMSCs,采用BKca通道特异性开放剂msl619）和拮抗剂（IBTX）干预,MTT、平板克隆测定细胞增殖活力及细胞克隆形成能力;流式细胞术分析细胞凋亡及细胞周期分布;Westernblot、定量PCR检测周期蛋白cyclinD1基因和蛋白表达水平;整细胞膜片钳技术分析细胞膜电生理特性。结果显示,NS1619干预组与对照组相比,BMSCs~胞膜科通道外向电流振幅增大,细胞增殖能力和克隆形成能力增强,凋亡减少。此外,开放BKca通道明显促进细胞从G1期向S期过渡,cyclinD1蛋白7LmRNA表达上调,而拮抗BKca通道则相反。推测,BKca通道通过调节细胞周期进程最终影响细胞增殖,该作用可能与其具有调控细胞膜心电流的电生理特性有关。     

BKCa通道的结构与功能

BKCa通道将细胞膜电特性与细胞信号系统联系在一起,在细胞功能实现中起着重要作用。该通道广泛且又较高密度地表达于许多物种的多种组织,其分子结构复杂,丰富的超家族成员具有各自不同的表达分布。BKCa通道的分子结构由α亚单位和β亚单位构成,其中α亚单位形成通道的孔道区和活性调节区域,β亚单位修饰通道活性的调节特性。BKCa通道开放几率大、电导率高、调控位点多,并且不同的超家族成员表现出不同的功能特征,如细胞膜电位感受性、细胞内游离钙离子敏感性等。文章概述BKCa通道的分子结构和功能特征。     

Physiological and pathophysiological roles of ATP-sensitive K+ channels

ATP-sensitive potassium (K(ATP)) channels are present in many tissues, including pancreatic islet cells, heart, skeletal muscle, vascular smooth muscle, and brain, in which they couple the cell metabolic state to its membrane potential, playing a crucial role in various cellular functions. The K(ATP) channel is a hetero-octamer comprising two subunits: the pore-forming subunit Kir6.x (Kir6.1 or Kir6.2) and the regulatory subunit sulfonylurea receptor SUR (SUR1 or SUR2). Kir6.x belongs to the inward rectifier K(+) channel family; SUR belongs to the ATP-binding cassette protein superfamily. Heterologous expression of differing combinations of Kir6.1 or Kir6.2 and SUR1 or SUR2 variant (SUR2A or SUR2B) reconstitute different types of K(ATP) channels with distinct electrophysiological properties and nucleotide and pharmacological sensitivities corresponding to the various K(ATP) channels in native tissues. The physiological and pathophysiological roles of K(ATP) channels have been studied primarily using K(ATP) channel blockers and K(+) channel openers, but there is no direct evidence on the role of the K(ATP) channels in many important cellular responses. In addition to the analyses of naturally occurring mutations of the genes in humans, determination of the phenotypes of mice generated by genetic manipulation has been successful in clarifying the function of various gene products. Recently, various genetically engineered mice, including mice lacking K(ATP) channels (knockout mice) and mice expressing various mutant K(ATP) channels (transgenic mice), have been generated. In this review, we focus on the physiological and pathophysiological roles of K(ATP) channels learned from genetic manipulation of mice and naturally occurring mutations in humans.     

Differential efficacy of GoSlo-SR compounds on BKα and BKαγ1–4 channels

Large conductance, voltage and Ca²⁺ activated K⁺ channels (BK channels) are abundantly expressed throughout the body and are important regulators of smooth muscle tone and neuronal excitability. Their dysfunction is implicated in various diseases including overactive bladder, hypertension and erectile dysfunction. Therefore, BK channel openers bear significant therapeutic potential to treat the above diseases. GoSlo-SR compounds were designed to be potent and efficacious BK channel openers. Although their structural activity relationships, activation in both BKα and BKαβ channels and the hypothetical mode of action of these compounds has been studied in detail in recent years, their effectiveness to open the BKαγ channels still remains unexplored. In this study, we have examined the efficacy of 3 closely related GoSlo-SR openers, GoSlo-SR-5-6 (SR-5-6), GoSlo-SR-5-44 (SR-5-44) and GoSlo-SR-5-130 (SR-5-130) using inside out patches on BKα channels coexpressed with 4 different LRRC (γ_1–4) subunits in HEK293 cells. Our data suggests that the activation effects due to SR-5-6 were not significantly affected in the presence of γ_1–4 subunits. Interestingly, the effects of more efficacious BK channel opener SR-5-44 were altered by different γ subunits. In cells expressing BKα channels, the shift in V_1/2 (ΔV_1/2) induced by SR-5-44 (3 μM) was ?76 ± 3 mV, whereas it was significantly reduced by ～70 % in BKαγ₁ channels (ΔV_1/2= ?23 ± 3, p < 0.001, ANOVA). In BKαγ₂ channels the ΔV_1/2 was ?36 ± 1 mV, which was less than that observed in BKαγ₃ and BKαγ₄ channels where the ΔV_1/2 was ?47 ± 5 mV, and ?82 ± 5 mV, respectively. Additionally, the excitatory effects of a ‘β specific’ BK channel opener, SR-5-130 were only partially restored in the patches containing BKαγ_1–4 channels. Together this data highlights that subtle modifications in GoSlo-SR structures alter their effectiveness on BK channels with accessory γ subunits and this study might provide a scaffold for the development of more tissue specific BK channel openers.     

Reactive oxygen species impair Slo1 BK channel function by altering cysteine-mediated calcium sensing

Vascular dysfunction is a hallmark of many diseases, including coronary heart disease, stroke and diabetes. The underlying mechanisms of these disorders, which are intimately associated with inflammation and oxidative stress caused by excess reactive oxygen species (ROS), have remained elusive. Here we report that ROS are powerful inhibitors of vascular smooth muscle calcium-dependent Slo1 BK or Maxi-K potassium channels, an important physiological determinant of vascular tone. By targeting a cysteine residue near the Ca(2+) bowl of the BK alpha subunit, H(2)O(2) virtually eliminates physiological activation of the channel, with an inhibitory potency comparable to a knockout of the auxiliary subunit BK beta 1. These results reveal a molecular structural basis for the vascular dysfunction involving oxidative stress and provide a solid rationale for a potential use of BK openers in the prevention and treatment of cardiovascular disorders.     

检测钾离子通道的小分子荧光探针的研究进展

钾离子通道是分布最为广泛、种类繁多的一类离子通道,因其生理功能的多样性,已成为许多疾病的药物作用靶点。近年来,许 多化学结构不同的药物均因钾离子通道阻滞引起的严重心肌毒性而被撤出市场,使得小分子药物的钾通道抑制活性筛选面临重大挑战。 介绍检测钾离子通道的小分子荧光探针的研究进展,并总结小分子荧光探针的作用机制,为今后小分子荧光探针的设计提供思路,使得 小分子荧光探针可以广泛应用于候选药物的高通量筛选、钾离子通道的活体成像与检测。     

TRPM7 and its role in neurodegenerative diseases

Calcium (Ca²⁺) and magnesium (Mg²⁺) ions have been shown to play an important role in regulating various neuronal functions. In the present review we focus on the emerging role of transient potential melastatin-7 (TRPM7) channel in not only regulating Ca²⁺ and Mg²⁺ homeostasis necessary for biological functions, but also how alterations in TRPM7 function/expression could induce neurodegeneration. Although eight TRPM channels have been identified, the channel properties, mode of activation, and physiological responses of various TRPM channels are quite distinct. Among the known 8 TRPM channels only TRPM6 and TRPM7 channels are highly permeable to both Ca²⁺ and Mg²⁺; however here we will only focus on TRPM7 as unlike TRPM6, TRPM7 channels are abundantly expressed in neuronal cells. Importantly, the discrepancy in TRPM7 channel function and expression leads to various neuronal diseases such as Alzheimer disease (AD) and Parkinson disease (PD). Further, it is emerging as a key factor in anoxic neuronal death and in other neurodegenerative disorders. Thus, by understanding the precise involvement of the TRPM7 channels in different neurodegenerative diseases and by understanding the factors that regulate TRPM7 channels, we could uncover new strategies in the future that could evolve as new drug therapeutic targets for effective treatment of these neurodegenerative diseases.     

A specific binding site for K+ channel openers in rat aorta.

The K+ channel openers, including cromakalim, pinacidil, minoxidil sulfate, diazoxide, and nicorandil, form a chemically heterogeneous group of compounds, which relax smooth muscle by opening plasmalemmal K+ channels. At present it is not known whether these drugs elicit their effects by binding to the same target, presumably the K+ channel. In order to address this question, a binding assay for K+ channel openers has been developed in vascular smooth muscle. The novel tritiated K+ channel opener, [3H]P1075, an analogue of pinacidil, binds with high affinity (KD = 6 +/- 1 nM) to endothelium-denuded rings of rat aorta. Inhibition studies indicate that the different families of K+ channel openers bind to a common target. Evidence is presented to suggest that the binding site for the sulfonylurea, glibenclamide, the major blocker of the K+ channel openers, is coupled in a negative allosteric manner to the binding site(s) for the openers. The binding assay described here may open the way to the biochemical characterization of the drug receptor for the K+ channel openers.     

TRPM7 and its role in neurodegenerative diseases

Calcium (Ca²⁺) and magnesium (Mg²⁺) ions have been shown to play an important role in regulating various neuronal functions. In the present review we focus on the emerging role of transient potential melastatin-7 (TRPM7) channel in not only regulating Ca²⁺ and Mg²⁺ homeostasis necessary for biological functions, but also how alterations in TRPM7 function/expression could induce neurodegeneration. Although eight TRPM channels have been identified, the channel properties, mode of activation, and physiological responses of various TRPM channels are quite distinct. Among the known 8 TRPM channels only TRPM6 and TRPM7 channels are highly permeable to both Ca²⁺ and Mg²⁺; however here we will only focus on TRPM7 as unlike TRPM6, TRPM7 channels are abundantly expressed in neuronal cells. Importantly, the discrepancy in TRPM7 channel function and expression leads to various neuronal diseases such as Alzheimer disease (AD) and Parkinson disease (PD). Further, it is emerging as a key factor in anoxic neuronal death and in other neurodegenerative disorders. Thus, by understanding the precise involvement of the TRPM7 channels in different neurodegenerative diseases and by understanding the factors that regulate TRPM7 channels, we could uncover new strategies in the future that could evolve as new drug therapeutic targets for effective treatment of these neurodegenerative diseases.     

Pathophysiology of voltage-gated K channels in vascular smooth muscle cells: Modulation by protein kinases

In this review, the pathological alteration and clinical relevance of voltage-gated K⁺ (Kv) channels and their specific regulation by protein kinase-dependent signaling in vascular smooth muscle cells are described, particularly focusing on the pulmonary vasculature. The physiological relevance, channel characteristics, pharmacological modulation, and expression of Kv channels vary between different arterial beds and between subdivisions of arteries within those vascular beds. Although detailed signaling cascades regulating Kv channels are not clearly elucidated, it is known that the Kv channels in vascular smooth muscle cells can be tightly regulated by protein kinases C (PKC) and A (PKA). Alterations in Kv channel expression and function has been noted in pathological and pathophysiological conditions including hypertension (pulmonary and systemic), in diabetes and in individuals subjected to prolonged hypoxia (high altitude living). Vascular Kv channels are potential therapeutic targets in diseases such as pulmonary arterial hypertension and, therefore, it is important to understand the specific pharmacological modulation of Kv channel isoforms in different vascular beds.     

慢性吸烟大鼠气道平滑肌大电导的钙激活钾通道和Kv1.5表达的变化

复制大鼠的慢性吸烟模型,采用气道反应性的测定、HE染色、免疫组织化学染色、原位杂交和免疫印迹实验等方法,观察吸烟对大鼠支气管平滑肌大电导的钙激活的钾通道(BKca)和电压依赖性延迟整流钾通道Kv1．5蛋白和mRNA表达的影响,以阐明吸烟引起的气道高反应性发病机制中钾通道表达变化的作用。结果显示：(1)慢性吸烟可降低大鼠大气道和小气道BKca和Kv1．5蛋白和mRNA表达;(2)大气道BKca的降低程度大于Kv1．5,小气道BKca和Kv1．5的降低程度无明显差异：(3)吸烟对全肺组织BKca和Kv1．5的蛋白表达无明显影响。上述结果提示,慢性吸烟可下调大鼠气道平滑肌钾通道BKca和Kv1．5的表达水平,是导致气道高反应的机制之一。